Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMX Mesalamine Maintenance in Quiescent Ulcerative Colitis
NCT00446849Phase 4Completed
- Sponsor
- Takeda
- Start
- May 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Salcrozine in ulcerative colitis (UC), sponsored by Takeda. Started May 2007; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00446849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446849.